Sbi Securities Co., Ltd. Cytokinetics Inc Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in Cytokinetics Inc stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 62 shares of CYTK stock, worth $3,125. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62Holding current value
$3,125% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CYTK
# of Institutions
406Shares Held
125MCall Options Held
4.6MPut Options Held
2.42M-
Black Rock Inc. New York, NY14.7MShares$740 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$593 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.69MShares$488 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.77MShares$392 Million0.07% of portfolio
-
State Street Corp Boston, MA6.46MShares$326 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.75B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...